Abingdon, United Kingdom

David Festus Moffat


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Festus Moffat: Innovator in Enzyme Inhibitors

Introduction

David Festus Moffat is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of enzyme inhibitors, particularly in the context of cancer treatment. With a total of two patents to his name, Moffat's work is recognized for its potential impact on medical science.

Latest Patents

Moffat's latest patents focus on enzyme inhibitors, specifically compounds of formula (I) that act as inhibitors of histone deacetylase activity. These compounds are particularly useful in the treatment of various cancers, showcasing Moffat's commitment to advancing therapeutic options in oncology.

Career Highlights

Moffat is currently associated with Chroma Therapeutics Limited, where he continues to innovate and develop new solutions in the field of biochemistry. His work has garnered attention for its scientific rigor and potential applications in medicine.

Collaborations

Moffat has collaborated with esteemed colleagues such as Alan Hornsby Davidson and Sanjay Ratilal Patel. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

David Festus Moffat stands out as a significant figure in the realm of enzyme inhibitors, with a focus on cancer treatment. His contributions through patents and collaborations highlight his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…